4.2 Article

Molecular cloning and expression in Pichia pastoris of a hypoallergenic antigen 5

Journal

PROTEIN EXPRESSION AND PURIFICATION
Volume 73, Issue 1, Pages 23-30

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.pep.2010.03.029

Keywords

Pichia pastoris; Recombinant protein; Optimization procedures; Antigen 5; Allergy; Immunotherapy

Funding

  1. Universidad de Buenos Aires
  2. Consejo Nacional de Investigaciones Cientificas y Tecnicas de la Republica Argentina

Ask authors/readers for more resources

Stings by insects from the Hymenoptera order can cause life-threatening allergic reactions and impair life quality. Immunotherapy with venom extracts is the most extensively employed treatment to reduce morbidity and mortality, but purified and safer allergy vaccines are needed. Antigen 5 is an important allergen of vespid venoms. We previously reported that Antigen 5 from Polybia scutellaris (Poly s 5) is likely to be a hypoallergenic variant. On the basis of such findings, this work deals with the recombinant expression and purification of Poly s 5 in Pichia pastoris. In order to overcome non-native glycosylation of the recombinant protein, it was necessary to delete a glycosylation site. On the other hand, different strategies were attempted to obtain a satisfactory yield of the protein; moreover, the influence of the methanol concentration in the expression medium was investigated and found to be crucial. Mass spectrometry, N-terminal sequencing, and IgG-binding inhibition assays were performed. Results allowed us to confirm the immunological equivalence between the recombinant and the natural proteins. In conclusion, a novel protocol for the recombinant expression of Poly s 5 in P. pastoris was designed thus bringing about a high yield of the protein useful for clinical and scientific purposes. (C) 2010 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Editorial Material Biotechnology & Applied Microbiology

HPV vaccination for prevention of skin cancer

Sabrina E. Vinzon, Frank Roesl

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)

Article Biochemical Research Methods

In vivo/ex vivo targeting of Langerhans cells after topical application of the immune response modifier TMX-202: confocal Raman microscopy and histology analysis

Maxim E. Darvin, Gisela Thiede, Saul Mujica Ascencio, Sabine Schanzer, Heike Richter, Sabrina E. Vinzon, Daniel Hasche, Frank Roesl, Roberto May, Yohan Hazot, Dov Tamarkin, Juergen Lademann

JOURNAL OF BIOMEDICAL OPTICS (2016)

Article Biotechnology & Applied Microbiology

Transcriptome analysis of Mastomys natalensis papillomavirus in productive lesions after natural infection

Melanie Salvermoser, Sasithorn Chotewutmontri, Ilona Braspenning-Wesch, Daniel Hasche, Frank Roesl, Sabrina E. Vinzon

JOURNAL OF GENERAL VIROLOGY (2016)

Article Microbiology

The interplay of UV and cutaneous papillomavirus infection in skin cancer development

Daniel Hasche, Sonja Stephan, Ilona Braspenning-Wesch, Julita Mikulec, Martina Niebler, Hermann-Josef Groene, Christa Flechtenmacher, Baki Akguel, Frank Roesl, Sabrina E. Vinzon

PLOS PATHOGENS (2017)

Review Microbiology

Cutaneous Papillomaviruses and Non-melanoma Skin Cancer: Causal Agents or Innocent Bystanders?

Daniel Hasche, Sabrina E. Vinzon, Frank Roesl

FRONTIERS IN MICROBIOLOGY (2018)

Article Multidisciplinary Sciences

A Naturally Occurring Hypoallergenic Variant of Vespid Antigen 5 from Polybia scutellaris Venom as a Candidate for Allergen-Specific Immunotherapy

Sabrina E. Vinzon, Cristina Marino-Buslje, Elena Rivera, Mirtha Biscoglio de Jimenez Bonino

PLOS ONE (2012)

Article Multidisciplinary Sciences

Establishment of an Immortalized Skin Keratinocyte Cell Line Derived from the Animal Model Mastomys coucha

Daniel Hasche, Sonja Stephan, Larissa Savelyeva, Frank Westermann, Frank Roesl, Sabrina E. Vinzon

PLOS ONE (2016)

Article Pharmacology & Pharmacy

Biochemical characterization of the Micrurus pyrrhocryptus venom

Jose Christian Dokmetjian, Sergio del Canto, Sabrina Vinzon, Mirtha Biscoglio de Jimenez Bonino

TOXICON (2009)

Article Microbiology

Protective Vaccination against Papillomavirus-Induced Skin Tumors under Immunocompetent and Immunosuppressive Conditions: A Preclinical Study Using a Natural Outbred Animal Model

Sabrina E. Vinzon, Ilona Braspenning-Wesch, Martin Mueller, Edward K. Geissler, Ingo Nindl, Hermann-Josef Groene, Kai Schaefer, Frank Roesl

PLOS PATHOGENS (2014)

Article Biology

Expression of different L1 isoforms of Mastomys natalensis papillomavirus as mechanism to circumvent adaptive immunity

Yingying Fu, Rui Cao, Miriam Schaefer, Sonja Stephan, Ilona Braspenning-Wesch, Laura Schmitt, Ralf Bischoff, Martin Muller, Kai Schafer, Sabrina E. Vinzon, Frank Rosl, Daniel Hasche

ELIFE (2020)

Article Immunology

A Single Dose of a Hybrid hAdV5-Based Anti-COVID-19 Vaccine Induces a Long-Lasting Immune Response and Broad Coverage against VOC

M. Veronica Lopez, Sabrina E. Vinzon, Eduardo G. A. Cafferata, Felipe J. Nunez, Ariadna Soto, Maximiliano Sanchez-Lamas, M. Jimena Afonso, Diana Aguilar-Cortes, Gregorio D. Rios, Juliana T. Maricato, Carla T. Braconi, Vanessa B. Silveira, Tatiane M. Andrad, Tatiana C. S. Bonetti, Luiz M. Ramos Janini, Manoel J. B. C. Girao, Andrea S. Llera, Karina A. Gomez, Hugo H. Ortega, Paula M. Berguer, Osvaldo L. Podhajcer

Summary: A novel vaccine based on a chimeric human adenovirus 5 vector was developed, which induced potent humoral and T-cell immunity lasting at least 5 months by enhancing Spike expression, infection of muscle and dendritic cells, and utilizing stabilized Spike in a prefusion conformation. Vaccinated mice showed neutralizing antibodies against various Spike variants and maintained stable immunity for over 5 months, suggesting potential for clinical trials.

VACCINES (2021)

Article Immunology

Cross-protection and cross-neutralization capacity of ancestral and VOC-matched SARS-CoV-2 adenoviral vector-based vaccines

Sabrina E. Vinzon, Maria V. Lopez, Eduardo G. A. Cafferata, Ariadna S. Soto, Paula M. Berguer, Luciana Vazquez, Leonora Nusblat, Andrea V. Pontoriero, Eduardo M. Belotti, Natalia R. Salvetti, Diego L. Viale, Ariel E. Vilardo, Martin M. Avaro, Estefania Benedetti, Mara L. Russo, Maria E. Dattero, Mauricio Carobene, Maximiliano Sanchez-Lamas, Jimena Afonso, Mauro Heitrich, Alejandro E. Cristofalo, Lisandro H. Otero, Elsa G. Baumeister, Hugo H. Ortega, Alexis Edelstein, Osvaldo L. Podhajcer

Summary: The study demonstrates the cross-protective and cross-neutralizing capacity of vaccines expressing variant-matched Spike protein in rodent models, with varying levels of protection observed against different variants. The use of a booster with a distant variant-based vaccine enhances neutralizing capacity and provides broader protection against SARS-CoV-2 lineages.

NPJ VACCINES (2023)

Article Biochemical Research Methods

Antibody-mimetic drug conjugate with efficient internalization activity using anti-HER2 VHH and duocarmycin

Juri Sakata, Toshifumi Tatsumi, Akira Sugiyama, Akihiro Shimizu, Yuya Inagaki, Hiroto Katoh, Takefumi Yamashita, Kazuki Takahashi, Sho Aki, Yudai Kaneko, Takeshi Kawamura, Mai Miura, Masazumi Ishii, Tsuyoshi Osawa, Toshiya Tanaka, Shumpei Ishikawa, Masanobu Tsukagoshi, Michael Chansler, Tatsuhiko Kodama, Motomu Kanai, Hidetoshi Tokuyama, Kenzo Yamatsugu

Summary: This study reports an expression, refolding, and purification method for antibody-mimetic drug conjugate (AMDC). The AMDC uses a variable heavy chain of heavy chain-only antibodies (VHHs) as the targeting protein and non-covalently binds to a potent DNA-alkylating drug. The AMDC shows strong cytotoxic effects on cancer cells.

PROTEIN EXPRESSION AND PURIFICATION (2024)

Article Biochemical Research Methods

A transmembrane scaffold from CD20 helps recombinant expression of a chimeric claudin 18.2 in an in vitro coupled transcription and translation system

Yao Wang, Shaoting Weng, Yajie Tang, Sen Lin, Xiayue Liu, Wenhui Zhang, Gang Liu, Boomi Pandi, Yinrong Wu, Lei Ma, Lin Wang

Summary: In this study, a high yield of recombinant CD20 and claudin 18.2 proteins was achieved using an in vitro coupled transcription-translation system. The results showed that rituximab has a high affinity with CD20 protein. This study provides a novel concept for promoting the expression of multi-pass transmembrane proteins and lays the foundation for large-scale industrial production of membrane-associated drug targets.

PROTEIN EXPRESSION AND PURIFICATION (2024)

Article Biochemical Research Methods

α-Conotoxin recombinant protein ImI-AFP3 efficiently inhibits the growth and migration of lung cancer cells

Xiaobing Chen, Zijuan Zou, Wei Li, Xu Dong, Yi Chen, Yan Lu, Mingyue Zhu, Mengsen Li, Bo Lin

Summary: In this study, the fusion protein ImI-AFP3, composed of alpha-Conotoxin ImI and human alpha fetoprotein domain 3 (AFP3), was found to inhibit the growth and migration of lung cancer cells and showed synergistic effects with the drug gefitinib. These findings suggest that ImI-AFP3 is a promising candidate for the development of anticancer drugs.

PROTEIN EXPRESSION AND PURIFICATION (2024)

Article Biochemical Research Methods

Cytoplasmic production of Fabs in chemically defined media in fed-batch fermentation

Angel Castillo-Corujo, Mirva J. Saaranen, Lloyd W. Ruddock

Summary: This study successfully expressed two Fabs antibodies in the cytoplasm of E. coli using the CyDisCo system, achieving high yields and biological activity under industrially relevant fermentation conditions.

PROTEIN EXPRESSION AND PURIFICATION (2024)

Article Biochemical Research Methods

An archaeal nitrile hydratase from the halophilic archaeon A07HB70 exhibits high tolerance to 3-cyanopyridine and nicotinamide

Junling Guo, Zhongyi Cheng, Zhemin Zhou

Summary: This study focused on a halophilic archaeal nitrile hydratase (NHase) and found that it exhibited higher tolerance to substrates and products compared to NHases from other sources. The unique genetic structure of this highly stable archaeal NHase could provide a theoretical foundation for modifying and enhancing the industrial application of NHase.

PROTEIN EXPRESSION AND PURIFICATION (2024)

Article Biochemical Research Methods

Generation of a blockage monoclonal antibody of LILRB1 against HLA-G

Yunlong Shen, Ruirui Zhang, Xiaohua Jiang, Jinliang Yang

Summary: The study developed a monoclonal antibody, B1M023, that can bind to LILRB1 with high affinity and block its binding to HLA-G. This antibody can promote the activation and IFN-gamma secretion of T cells, suggesting its potential applications in concomitant diagnosis and tumor immunotherapy.

PROTEIN EXPRESSION AND PURIFICATION (2024)

Article Biochemical Research Methods

Biochemical characterization of a novel bifunctional alginate lyase from Microbulbifer arenaceous

Jun Jiang, Zhengqiang Jiang, Qiaojuan Yan, Susu Han, Shaoqing Yang

Summary: A novel alginate lyase gene from a marine bacterium showed efficient enzyme activity and stability, producing high conversion ratios of alginate oligosaccharides.

PROTEIN EXPRESSION AND PURIFICATION (2024)

Article Biochemical Research Methods

Generation and characterization of a monoclonal antibody against FGFR3 that protects mice from BoNT/A

Xianghua Xiong, Yujin Qiu, Jiahao Zheng, Ling Zhou, Qingyang Wang, Jinglun Pang, Weicai Zhang, Huipeng Chen, Gang Liu, Xiaodong Han

Summary: A specific monoclonal antibody ML419 has been found to disrupt the recognition between Botulinum neurotoxin serotype A (BoNT/A) and FGFR3, effectively preventing BoNT/A from entering neurons. In vivo experiments show that ML419 has a strong protective effect, making it a promising candidate for the development of therapeutics against BoNT/A.

PROTEIN EXPRESSION AND PURIFICATION (2024)

Article Biochemical Research Methods

Optimized expression and purification of a human adenosine deaminase in E. coli and characterization of its Asp8Asn variant

Maria Rain Jennings, Soohyon Min, Grace S. Xu, Kassandra Homayuni, Bhavana Suresh, Yusef Amir Haikal, John Blazeck

Summary: This study successfully produced Homo sapiens adenosine deaminase isoform 1 (HsADA1) and its variants through optimizing the recombinant expression process. The D8N variant of HsADA1 was found to be about 30% less active than the wildtype, but it better retained its activity in human serum. Additionally, the study revealed a previously undescribed phenomenon involving albumin that contributed to the increased activity of HsADA1 and the D8N variant in serum.

PROTEIN EXPRESSION AND PURIFICATION (2024)

Article Biochemical Research Methods

Purification and characterization of an asialofetuin specific lectin from the rhizome of Xanthosoma violaceum Schott

Oinam Sangita Devi, Senjam Sunil Singh, K. Rana, Sorokhaibam Jibankumar Singh, Wayenbam Sobhachandra Singh

Summary: A new lectin with hemagglutination activity was purified from the rhizome of Xanthosoma violaceum Schott. The lectin showed different reactions towards human red blood cells of different blood groups. It exhibited optimal hemagglutination activity at specific temperature and pH range, and showed good stability.

PROTEIN EXPRESSION AND PURIFICATION (2024)